AskBio to Present Phase 1b Results Investigating AB-1005 (formerly AAV2-GDNF) as Treatment for Parkinson’s Disease at AD/PDTM 2023 International Conference on Alzheimer’s and Parkinson’s Diseases

—Preliminary data suggest that gene therapy via neurosurgical administration is generally safe, well tolerated and associated with enhanced mean putaminal coverage and clinical improvements— —Study uses one-time MRI-monitored surgery for delivery in patients with mild to moderate…